» Articles » PMID: 37507788

Psychoactive Drugs and Male Fertility: Impacts and Mechanisms

Overview
Publisher Biomed Central
Date 2023 Jul 28
PMID 37507788
Authors
Affiliations
Soon will be listed here.
Abstract

Although psychoactive drugs have their therapeutic values, they have been implicated in the pathogenesis of male infertility. This study highlights psychoactive drugs reported to impair male fertility, their impacts, and associated mechanisms. Published data from scholarly peer-reviewed journals were used for the present study. Papers were assessed through AJOL, DOAJ, Google Scholar, PubMed/PubMed Central, and Scopus using Medical Subjects Heading (MeSH) indexes and relevant keywords. Psychoactive drugs negatively affect male reproductive functions, including sexual urge, androgen synthesis, spermatogenesis, and sperm quality. These drugs directly induce testicular toxicity by promoting ROS-dependent testicular and sperm oxidative damage, inflammation, and apoptosis, and they also suppress the hypothalamic-pituitary-testicular axis. This results in the suppression of circulating androgen, impaired spermatogenesis, and reduced sperm quality. In conclusion, psychoactive drug abuse not only harms male sexual and erectile function as well as testicular functions, viz., testosterone concentration, spermatogenesis, and sperm quality, but it also alters testicular histoarchitecture through a cascade of events via multiple pathways. Therefore, offering adequate and effective measures against psychoactive drug-induced male infertility remains pertinent.

Citing Articles

Synthetic Cathinones Induce Developmental Arrest, Reduce Reproductive Capacity, and Shorten Lifespan in the Model.

Mendes C, Maia D, Dinis-Oliveira R, Remiao F, Silva R, Barbosa D J Xenobiot. 2025; 15(1).

PMID: 39997376 PMC: 11856764. DOI: 10.3390/jox15010033.


Does coenzyme Q10 improve semen quality and circulating testosterone level? a systematic review and meta-analysis of randomized controlled trials.

Akhigbe T, Fidelis F, Adekunle A, Ashonibare V, Akorede B, Shuaibu M Front Pharmacol. 2025; 15():1497930.

PMID: 39830337 PMC: 11739123. DOI: 10.3389/fphar.2024.1497930.


Histopathological evaluation of infertility: Lessons from laboratory rodents.

Ricken A, Hamed M, Akhigbe R Histol Histopathol. 2023; 39(6):671-690.

PMID: 38088133 DOI: 10.14670/HH-18-684.

References
1.
Rodriguez M, Sanchez-Yague J, Paniagua R . Effects of cocaine on testicular structure in the rat. Reprod Toxicol. 1992; 6(1):51-5. DOI: 10.1016/0890-6238(92)90020-t. View

2.
Sansone A, Di Dato C, de Angelis C, Menafra D, Pozza C, Pivonello R . Smoke, alcohol and drug addiction and male fertility. Reprod Biol Endocrinol. 2018; 16(1):3. PMC: 5769315. DOI: 10.1186/s12958-018-0320-7. View

3.
Valenti D, La Vignera S, Condorelli R, Rago R, Barone N, Vicari E . Follicle-stimulating hormone treatment in normogonadotropic infertile men. Nat Rev Urol. 2012; 10(1):55-62. DOI: 10.1038/nrurol.2012.234. View

4.
Anderson L, Flynn A, Pilgrim J . A global epidemiological perspective on the toxicology of drug-facilitated sexual assault: A systematic review. J Forensic Leg Med. 2017; 47:46-54. DOI: 10.1016/j.jflm.2017.02.005. View

5.
Paulis M, Hafez E, El-Tahawy N . Toxicity and postwithdrawal effects of ketamine on the reproductive function of male albino rats: Hormonal, histological, and immunohistochemical study. Hum Exp Toxicol. 2020; 39(8):1054-1065. DOI: 10.1177/0960327120909857. View